⌘K

Home/Filings/4/0001437749-22-004668

4//SEC Filing

Guse Kyle 4

Accession 0001437749-22-004668

CIK 0001488039other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 5:15 PM ET

Size

4.9 KB

Accession

0001437749-22-004668

Insider Transaction Report

Form 4

Period: 2022-02-24

ATOSSA THERAPEUTICS, INC.ATOS

CFO & General Counsel

Transactions

Award
Stock Option (right to buy)
2022-02-24+746,667→ 746,667 total
Exercise: $1.25Exp: 2032-02-24→ Common Stock (746,667 underlying)

Footnotes (1)

[F1]The options will vest on a quarterly basis over two (2) years.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

ATOSSA THERAPEUTICS, INC.

CIK 0001488039

Entity typeother

Related Parties

1

filerCIK 0001566618

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 5:15 PM ET
Size: 4.9 KB

View on SEC.gov